期刊文献+

米非司酮对妊娠中期胎儿肝脏超微结构的影响

Effect of Mifepristone on the ultrastructure of fetal liver in the second trimester pregnancy
暂未订购
导出
摘要 目的:探讨米非司酮对妊娠中期胎儿肝脏超微结构的影响。方法:将中期引产孕妇随机分为两组:对照组(水囊组)10例,实验组(米非司酮+水囊组)15例。实验组按孕龄分为实验Ⅰ组(n=10,16—22周)和实验Ⅱ组(n=5,23—28周)。实验组口服米非司酮100mg,连服3d,行水囊引产,对照组只行水囊引产。胎儿娩出后取肝脏组织进行样本制备,然后在电镜下观察肝脏组织细胞的超微结构。结果:肝脏组织细胞的超微结构有改变,且孕龄越小,超微结构改变越明显:①肝细胞肿胀,可见细胞连接;②大部分肝细胞核空化;③胞质空化,内可见少量粗面内质网及线粒体,脂褐素和糖原颗粒散在于细胞质内;④部分线粒体肿胀、空化、嵴断裂;⑤细胞之间有淋巴细胞浸润。结论:米非司酮可以引发胎儿肝脏组织的缺血缺氧性改变。 Objective To explore the effect of Mifepristone on the ultrastructure of the fetal liver in the second trimester pregnancy induced labor. Method 25 normal pregnant women were randomly divided into two groups: the control group (n = 10, average gestation of 22 weeks) was given waterbag induced labor alone and the test group (n = 15, average gestation of 22 weeks)was divided into two groups as the test group Ⅰ (n = 10, gestation of 16 -22 weeks), the test group Ⅱ (n =5, gestation of 23 -28 weeks). The test group took Mifepristone orally, 100mg per day for 3 days, then was given waterbag induced labor. After delivery of fetus, fetal liver was separated immediately for observation by transmission electron microscopic examination. Results Compared with the control group, the test group showed significant ultrastructure changes of the fetal liver and the earlier stage the fetus in, the more obvious ultrastructure changes were : (1)liver cellswelled and cell junctions were found; (2)some nuclei cavitation was seen; (3)cell matrix cavitation, manipulus rough endoplasmic reticulum and mitochondria, scattered lipofusion and glycogen granules were showed; (4)mitochondria swelled and cristae disrupted; (5)leukomonocytes infiltrated. Conclusion Mifepristone can result in ischemia and hypoxia changes in the ultrastructure of the fetal liver in the second trimester pregnancy induced labor.
出处 《吉林医学》 CAS 2007年第3期314-315,317,共3页 Jilin Medical Journal
关键词 米非司酮 胎儿 肝脏 超微结构 Mifepristone Fetus Liver Uhrastructure
  • 相关文献

参考文献12

二级参考文献36

  • 1桑国卫,翁黎驹,邵庆翔,杜明昆,吴学浙,卢玉兰,程利南.不同剂量米非司酮和米索前列醇终止早孕的临床研究[J].中华妇产科杂志,1994,29(12):735-738. 被引量:267
  • 2翁梨驹.米非司酮的研究进展[J].中华妇产科杂志,1995,30(9):565-568. 被引量:385
  • 3周剑萍,张俊慧,刘银坤,孙翠翔,陆湘云.米非司酮对人蜕膜与绒毛糖脂及雌孕激素受体的影响[J].生殖与避孕,1996,16(5):357-360. 被引量:28
  • 4马成斌,庄依亮,杨幼明,吕元.一氧化氮对妊高征发病的影响[J].中华妇产科杂志,1997,32(3):174-175. 被引量:14
  • 5Gemzell-Danielsson K, Ostlund E. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive eases. Aeta Obstet Gyneeol Scand, 2000;79 (8) :702.
  • 6Elliott CL, Brennand JE, Calder AA. The effects of mifepristone on cervical ripening and labor inductionin primigravidae. Obstet Gynecol, 1998; 92 : 804.
  • 7Hill NC, Selinger M, Ferguson J, et al.Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy. Hum Reprod,1991; 6 : 458.
  • 8Evain-Brion D. Hormonal regulation of fetal growth.Horm Res, 1994; 42: 207.
  • 9Miyazawa K. Role of epidermal growth factor in obstetrics and gynecology. Obstet Gynecol, 1992; 79 : 1032.
  • 10Gupta C. The role epidermal growth factor receptor(EGFR) in male reproductive tract differentiation:Stimulation of EGFR expression and inhibition of Wolf f Jan duet differentiation with anti- EGFR antibody. Endocrinology, 1996; 187 : 905.

共引文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部